David Kideckel
Vermögen: 10 080 $ am 31.07.2026
Vermögen: 10 080 $ am 31.07.2026
David M.
Kideckel is the founder of Kideckel Advisory Group, Inc., founded in 2021, where the title held is President & Chief Executive Officer.
Current jobs include Executive Chairman at Pharmadrug, Inc. starting in 2025; Director at Kane Biotech, Inc. starting in 2025; Chief Financial Officer & Director at Rakovina Therapeutics, Inc. starting in 2025; and EVP, Head-Strategy & Corporate Development at Delta 9 Cannabis, Inc. starting in 2021.
Former jobs include Analyst & Managing Director at ATB Cormark Capital Markets Inc. from 2018 to 2021; Director of Equity Research at Beacon Securities Limited from 2017 to 2018; Principal at Origin Merchant Partners from 2022 to 2023; and Senior VP, Head-Corporate Development & Strategic at IntelGenx Technologies Corp.
Education includes an MBA from Rotman School of Management and a doctorate from the University of Toronto.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PHARMADRUG, INC. 1,03 % | 09.10.2025 | 1.380.000 ( 1,03 % ) | 8 280 $ | 31.07.2026 |
| 29.07.2025 | 20.000 ( 0,09 % ) | 1 800 $ | 31.07.2026 | |
KANE BIOTECH INC. -.--% | 28.05.2026 | 0 ( -.--% ) | - $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| HUMBLE GROW CO. | Corporate Officer/Principal | 16.08.2021 |
| PHARMADRUG INC. | Vorsitzender | 27.02.2024 |
| RAKOVINA THERAPEUTICS INC. | Finanzdirektor/CFO | 01.05.2025 |
| KANE BIOTECH INC. | Direktor/Vorstandsmitglied | 25.06.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
Origin Merchant Partners
Origin Merchant Partners Investment Banks/BrokersFinance Provides investment banking services | Corporate Officer/Principal | 01.01.2023 |
ATB Cormark Capital Markets Inc.
ATB Cormark Capital Markets Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01.08.2021 |
Beacon Securities Ltd.
Beacon Securities Ltd. Investment Banks/BrokersFinance Provides brokerage services | Direktor der Forschung - Eigenkapital | 01.10.2018 |
| INTELGENX TECHNOLOGIES CORP. | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Kane Biotech, Inc.
Kane Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that manufactures animal health oral care products | Commercial Services |
Rotman School of Management
Rotman School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ATB Cormark Capital Markets Inc.
ATB Cormark Capital Markets Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beacon Securities Ltd.
Beacon Securities Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
IntelGenx Technologies Corp.
IntelGenx Technologies Corp. Pharmaceuticals: MajorHealth Technology Operates as a drug delivery company that develops and manufactures oral film therapeutics | Health Technology |
Origin Merchant Partners
Origin Merchant Partners Investment Banks/BrokersFinance Provides investment banking services | Finance |
Delta 9 Cannabis, Inc.
Delta 9 Cannabis, Inc. Wholesale DistributorsDistribution Services Wholesales and retails cannabis products | Distribution Services |
Pharmadrug, Inc.
Pharmadrug, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development of cannabis-infused edible products and oil extracts | Health Technology |
Rakovina Therapeutics, Inc.
Rakovina Therapeutics, Inc. Financial ConglomeratesFinance Develops oncology therapeutics | Finance |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen